Financhill
Back

ProPhase Labs Stock Predictions

ProPhase Labs Stock Forecast

  • Is ProPhase Labs Stock Undervalued?
    The current ProPhase Labs [PRPH] share price is $0.63. The Score for PRPH is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will ProPhase Labs Stock Go Up Next Year?

Data Unavailable

ProPhase Labs Stock Rating

Data Unavailable

ProPhase Labs Stock Price History

Is PRPH stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
prophaselabs.com

52-Week Data

52-Week High:
7.48
52-Week Low:
0.61

Prediction Charts

Market Cap:
15M
Price in USD:
0.63
Volume:
41.1K
Beta:
0.52

Technical Analysis

SMA50:
1.27
SMA100:
1.89
SMA200:
3.36
52-Wk Change:
-86.42%

Stock Predictions

  • Is ProPhase Labs stock public?
    Yes, ProPhase Labs is a publicly traded company.
  • What is the ProPhase Labs stock quote today?
    The ProPhase Labs stock price is 0.63 USD today.
  • How to buy ProPhase Labs stock online?
    You can buy ProPhase Labs shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 0.72 0.71 0.76 0.66
Dec-6 0.70 0.70 0.75 0.68
Dec-9 0.70 0.72 0.72 0.68
Dec-10 0.70 0.67 0.73 0.67
Dec-11 0.68 0.65 0.75 0.64
Dec-12 0.65 0.68 0.70 0.64
Dec-13 0.67 0.65 0.67 0.64
Dec-16 0.68 0.69 0.72 0.67
Dec-17 0.69 0.69 0.74 0.69
Dec-18 0.67 0.72 0.72 0.66
Dec-19 0.70 0.65 0.72 0.65
Dec-20 0.65 0.61 0.70 0.61
Dec-23 0.62 0.63 0.66 0.62
Dec-24 0.64 0.63 0.68 0.63

ProPhase Labs Earnings

Data Unavailable

ProPhase Labs Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.